Reverse numbing drug to launch.Reverse Numbing Drug To Launch: A drug developed by privately-held Novalar Pharmaceuticals Inc. passed FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. muster May 12 and will launch later this year. The drug, OraVerse, works to reverse the numbing effects of local dental anesthesia for patients as young as 6 years old. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. clinical studies, the drug cut the medium time it took for full sensation to return to the lips by about 75 to 85 minutes, or by more than half. With more than 300 million anesthetic injections given each year in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , Novalar estimates it will reach hundreds of millions of dollars a year. The company said it would sell the drug to dentists for up to $20 an injection, although consumer costs would vary. "We are fully intending to take this onto market ourselves and to grow into a specialty pharma company in dentistry dentistry, treatment and care of the teeth and associated oral structures. Dentistry is mainly concerned with tooth decay, disease of the supporting structures, such as the gums, and faulty positioning of the teeth. ," said Donna Janson, president and chief executive of Novalar. "We are (pursuing) market opportunities whether it be an M&A or an IPO (Initial Public Offering) The first time a company offers shares of stock to the public. While not a computer term per se, many founders, employees and insiders of computer companies have found this acronym more exciting than any tech term they ever heard. ." Send news about biotechnology to Heather Chambers, hchambers@sdbj, com. |
|
||||||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion